Study of Bavituximab in Patients With Chronic Hepatitis C Virus Infection
Clinical trial NCT00128271 · COMPLETED
Trial details
- NCT number
- NCT00128271
- Sponsor
- Peregrine Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2005-08-01
- Primary completion
- 2006-08-01
- Enrollment
- 32
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.